Tokyo Tape
Sign in
← Ono Pharmaceutical

Quarterly report · Q3

4528.TEDINET S100Q0U7
Period2022-04-01 → 2022-12-31
Filed2023-02-03
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥339.0bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥122.3bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Revenue¥361.4bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥271.4bn2021-04-01 → 2021-12-31Cons.Revenue IFRS
Revenue¥97.4bn2021-10-01 → 2021-12-31dCons.Revenue IFRS
Operating income¥122.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥42.3bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥82.2bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥24.0bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥124.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥43.4bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥105.0bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥84.3bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥25.1bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥95.7bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥33.3bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥80.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥64.6bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥18.3bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥95.8bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥33.4bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥64.7bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥18.3bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥830.5bnat 2022-12-31Cons.Assets IFRS
Total assets¥739.2bnat 2022-03-31Cons.Assets IFRS
Total assets¥738.6bnat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥103.2bnat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥77.5bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥727.3bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥661.7bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥664.9bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥639.7bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥721.4bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥655.9bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥659.3bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥108.6bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.1bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥62.5bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥61.0bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥115.1bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥61.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥27.4bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥44.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥6.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥18.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥30.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥60.2bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥44.2bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥195.92022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥68.232022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥162.192021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥129.612021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥36.832021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥195.882022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥68.222022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥162.162021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥129.592021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥36.822021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio86.9%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio88.7%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio89.3%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 575
ItemContextValueUnit
Selling general and administrative expenses IFRSPrior1QuarterDuration19832000000JPY
Selling general and administrative expenses IFRSCurrentQuarterDuration23202000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration16912000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration26346000000JPY
Other income IFRSPrior1QuarterDuration76000000JPY
Other income IFRSCurrentQuarterDuration61000000JPY
Other expenses IFRSPrior1QuarterDuration11622000000JPY
Other expenses IFRSCurrentQuarterDuration438000000JPY
Operating profit loss IFRSPrior1QuarterDuration23996000000JPY
Operating profit loss IFRSCurrentQuarterDuration42320000000JPY
Finance income IFRSPrior1QuarterDuration1115000000JPY
Finance income IFRSCurrentQuarterDuration1185000000JPY
Finance costs IFRSPrior1QuarterDuration-8000000JPY
Finance costs IFRSCurrentQuarterDuration145000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1QuarterDuration0JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentQuarterDuration1000000JPY
Profit loss before tax IFRSPrior1QuarterDuration25118000000JPY
Profit loss before tax IFRSCurrentQuarterDuration43360000000JPY
Income tax expense IFRSPrior1QuarterDuration6783000000JPY
Income tax expense IFRSCurrentQuarterDuration9975000000JPY
Profit loss IFRSPrior1QuarterDuration18335000000JPY
Profit loss IFRSCurrentQuarterDuration33385000000JPY
Profit loss attributable to owners of parent IFRSPrior1QuarterDuration18330000000JPY
Profit loss attributable to owners of parent IFRSCurrentQuarterDuration33317000000JPY
Profit loss attributable to non controlling interests IFRSPrior1QuarterDuration5000000JPY
Profit loss attributable to non controlling interests IFRSCurrentQuarterDuration68000000JPY
Profit loss IFRSPrior1QuarterDuration18335000000JPY
Profit loss IFRSCurrentQuarterDuration33385000000JPY
Basic earnings loss per share IFRSPrior1QuarterDuration36.83
Basic earnings loss per share IFRSCurrentQuarterDuration68.23
Diluted earnings loss per share IFRSPrior1QuarterDuration36.82
Diluted earnings loss per share IFRSCurrentQuarterDuration68.22
Profit loss IFRSPrior1YTDDuration64669000000JPY
Profit loss IFRSCurrentYTDDuration95827000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration2709000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-743000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration556000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-41000000JPY
Share of net changes in the fair value of financial assets measured through other comprehensive income of entities accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-0JPY
Share of net changes in the fair value of financial assets measured through other comprehensive income of entities accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration3000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration3265000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-781000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration344000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration377000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration25000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-127000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration369000000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration250000000JPY
Other comprehensive income IFRSPrior1YTDDuration3634000000JPY
Other comprehensive income IFRSCurrentYTDDuration-530000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass